StockMarketWire.com - Orphan drug consultancy Open Orphan said it had signed a strategic collaboration agreement with Empiric Logic.

The pact would build on earlier work performed by Open Orphan and complete the build out of its Health Data platform, Europe's first rare disease, advocacy-led genomic database.

Empiric Logic would incorporate its software into Open Orphan's data platform platform to aid the collection and management capabilities of the software.


At 8:18am: [LON:ORPH] share price was 0p at 6.3p



Story provided by StockMarketWire.com